Search Within

David Fennelly

Formats
  1. Journal Article (25)
  2. Meeting Abstract (20)
  3. Conference Paper (4)
  4. Book Section (2)
Groups
  1. Department of Medicine (44)
  2. Solid Tumor Oncology Division (44)
  3. Breast Medicine Service (36)
  4. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (35)
  5. Survivorship Research (17)
  6. Behavioral Sciences Service (14)

More Groups

People
  1. Larry Norton (35)
  2. George Raptis (20)
  3. John Crown (19)
  4. Clifford Hudis (17)
  5. Andrew Seidman (15)
  6. David Spriggs (14)

More People

Years
  1. 1999 (4)
  2. 1998 (2)
  3. 1997 (6)
  4. 1996 (8)
  5. 1995 (14)
  6. 1994 (10)

More Years

Publications
  1. Blood (6)
  2. Gynecologic Oncology (6)
  3. Seminars in Oncology (6)
  4. Breast Cancer Research and Treatment (5)
  5. Journal of Clinical Oncology (4)
  6. Clinical Cancer Research (3)

More Publications

Publishers
  1. Elsevier Inc. (9)
  2. American Association for Cancer Research (7)
  3. American Society of Hematology (6)
  4. Elsevier B.V. (6)
  5. Springer (5)
  6. American Society of Clinical Oncology (4)

More Publishers

Results (51)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Sequential adjuvant therapy with doxorubicin/paclitaxel/cyclophosphamide for resectable breast cancer involving four or more axillary nodes
    Journal Article

    Hudis, C. A.; Seidman, A. D.; Baselga, J.; Raptis, G.; Lebwohl, D.; Gilewski, T.; Currie, V.; Moynahan, M. E.; Sklarin, N.; Fennelly, D.; more...
    Seminars in Oncology (1995)

    Fulltext@MSK | Save
  • Dose escalation of paclitaxel with high-dose cyclophosphamide, with analysis of progenitor-cell mobilization and hematologic support of advanced ovarian cancer patients receiving rapidly sequenced high-dose carboplatin/cyclophosphamide courses
    Journal Article

    Fennelly, D.; Schneider, J.; Spriggs, D.; Bengala, C.; Hakes, T.; Reich, L.; Barakat, R.; Curtin, J.; Moore, M. A. S.; Hoskins, W.; more...
    Journal of Clinical Oncology (1995)

    Fulltext@MSK | Save
  • Rapidly cycled courses of high-dose alkylating agents supported by filgrastim and peripheral blood progenitor cells in patients with metastatic breast cancer
    Journal Article

    Vahdat, L.; Raptis, G.; Fennelly, D.; Hamilton, N.; Reich, L.; Tiersten, A.; Harrison, M.; Hudis, C.; Moore, M.; Yao, T. J.; more...
    Clinical Cancer Research (1995)

    Fulltext@MSK | Save
  • A phase II trial of extracorporeal plasma immunoadsorption of patient plasma with PROSORBA columns for treating metastatic breast cancer
    Journal Article

    Fennelly, D. W.; Norton, L.; Sznol, M.; Hakes, T. B.
    Cancer (1995)

    Fulltext@MSK | Save
  • Taxol in combination with cyclophosphamide and GCSF, a novel peripheral blood progenitor cell mobilizing regimen
    Meeting Abstract

    Fennelly, D.; Bengala, C.; Schneider, J.; Hakes, T.; Spriggs, D.; Reich, L.; Yao, T. J.; Shapiro, F.; Norton, L.; Moore, M. A. S.; more...
    Proceedings of the American Association for Cancer Research Annual Meeting (1994)

    Fulltext@MSK | Save
  • Treatment of advanced ovarian cancer (AOC) with high-dose (HD) carboplatin (C) and escalating-dose taxol (TXL) with cyclophosphamide (CTX)/TXL-primed peripheral blood progenitor cells (PBP) as hematological support (HS): A phase I study
    Meeting Abstract

    Fennelly, D.; Schneider, J.; Hakes, T.; Crown, J.; Bengala, C.; Reich, L.; Moore, M.; Gulati, S.; Shapiro, F.; Barakat, R.; more...
    Gynecologic Oncology (1994)

    Fulltext@MSK | Save
  • Efficacy of prolonged paclitaxel (P) infusion after failure of prior short taxane infusion: A phase II and pharmacologic study in metastatic breast cancer (MBC)
    Meeting Abstract

    Hochhauser, D.; Seidman, A. D.; Gollub, M.; Edelman, B.; Hudis, C.; Francis, P.; Auguste, L.; Bellettieri, R.; Currie, V.; Gilewski, T.; more...
    Breast Cancer Research and Treatment (1994)

    Fulltext@MSK | Save
  • Phase I trial of sequential edatrexate (ETX) followed by paclitaxel (PTX) in patients with advanced breast cancer: A design based on in-vitro (IV) synergy
    Meeting Abstract

    Fennelly, D.; Hudis, C.; Seidman, A.; Hamilton, N.; Raptis, G.; Baselga, J.; Sklarin, N.; Norton, L.
    Breast Cancer Research and Treatment (1994)

    Fulltext@MSK | Save
  • Results of sequential dose-intensive adjuvant therapy with doxorubicin and cyclophosphamide
    Meeting Abstract

    Hudis, C.; Lebwohl, D.; Yao, T. J.; Crown, J.; Gilewski, T.; Currie, V.; Raptis, G.; Seidman, A.; Fennelly, D.; Kesselman, E.; more...
    Breast Cancer Research and Treatment (1994)

    Fulltext@MSK | Save
  • Rapidly administered sequential high dose(HD) cyclophosphamide(CPA), melphalan(M), thiotepa(TT) supported by filgrastim(G) + peripheral blood progenitors(PBP) in metastatic breast cancer(MBC) patients(PTS)
    Meeting Abstract

    Raptis, G.; Crown, J.; Vahdat, L.; Fennelly, D.; Hamilton, N.; Hudis, C.; Gilewski, T.; Seidman, A.; Currie, V.; Reich, L.; more...
    Breast Cancer Research and Treatment (1994)

    Fulltext@MSK | Save